tiprankstipranks

Vera Therapeutics price target lowered to $71 from $77 at JPMorgan

JPMorgan analyst Anupam Rama lowered the firm’s price target on Vera Therapeutics (VERA) to $71 from $77 and keeps an Overweight rating on the shares. The firm updated models in the Smid-cap biotechnology group post the Q4 reports.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue